OxySure Earnings Presentation - 1Q2014 v2.pdf May. 2014 | Page 13

Statement of cash flows Three Months Ended March 31, 2014 2013 Restated CASH FLOWS FROM OPERATING ACTIVITIES: Net income (loss) Three Months Ended March 31, 2014 2013 Restated CASH FLOWS FROM FINANCING ACTIVITIES Common stock issued for cash $ - 230,824 (93,500) - Cash received from convertible notes payable (376,320) - 28,103 Payments made on convertible notes payable (110,000) - (576) 12,881 - 3,500 (204,076) 275,308 (507,004) 81,390 657,673 13,514 $ (169,349) Payments made to related parties Adjustments to reconcile net income (loss) to net cash from operating activities: Depreciation and amortization expense Amortization of debt discount and beneficial conversion features Expenses paid by related parties Stock based compensation Gain on extinguishment of debt Stock issued for services Changes in operating assets and liabilities: Accounts receivable Inventories License fees receivable Prepaid expenses and other current assets Accounts payable and accrued liabilities Deferred revenue NET CASH USED IN OPERATING ACTIVITIES CASH FLOWS FROM INVESTING ACTIVITIES Purchase of property and equipment Purchase of intangible assets NET CASH USED IN INVESTING ACTIVITIES 12,141 35,610 95,776 4,374 17,588 (16,226) - 21,802 (12,061) 19,023 (272,816) 10,407 36,692 40,173 212,259 (2,976) (54,542) (142) 91,364 (125,000) (238,928) (193,295) Payments on capital leases Exercising of warrants NET CASH PROVIDED BY FINANCING ACTIVITIES Net change in cash and cash equivalents Cash and cash equivalents, at beginning of period Cash and cash equivalents, at end of period $ 94,905 $ $ 7,492 - $ - (623) - (64,000) 150,669 Supplemental disclosure of cash flow information: Cash paid during the period for: Interest Income taxes (64,000) - $ (623) 13